electroCore, Inc. Stock-Based Compensation
electroCore, Inc. (ECOR) reported Stock-Based Compensation of $755.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- electroCore, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $755.00K, a 49.50% increase year-over-year.
- electroCore, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.04M, a 91.85% increase year-over-year.
- electroCore, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $470.00K, a 8.56% decline year-over-year.
- electroCore, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $415.00K, a 3.75% increase year-over-year.
- electroCore, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $1.93M, a 3.21% increase from fiscal 2024.
- electroCore, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $1.87M, a 10.13% increase from fiscal 2023.
- electroCore, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $1.70M, a 36.69% decline from fiscal 2022.
- electroCore, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $2.68M, a 18.78% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $755.00K 10-Q · filed 2026-08-06 | $1.79M 10-Q · filed 2026-08-06 | $2.26M derived: sum of 3 quarters · filed 2026-08-06 | $2.68M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $1.04M 10-Q · filed 2026-05-06 | $1.51M derived: sum of 2 quarters · filed 2026-05-06 | $1.92M derived: sum of 3 quarters · filed 2026-05-06 | $2.43M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $470.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $885.00K derived: sum of 2 quarters · filed 2026-03-19 | $1.39M derived: sum of 3 quarters · filed 2026-08-06 | $1.93M 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | $415.00K 10-Q · filed 2025-11-05 | $920.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.46M 10-Q · filed 2025-11-05 | $1.97M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $505.00K 10-Q · filed 2026-08-06 | $1.04M 10-Q · filed 2026-08-06 | $1.56M derived: sum of 3 quarters · filed 2026-08-06 | $1.96M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $540.00K 10-Q · filed 2026-05-06 | $1.05M derived: sum of 2 quarters · filed 2026-05-06 | $1.45M derived: sum of 3 quarters · filed 2026-05-06 | $1.93M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $514.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $914.00K derived: sum of 2 quarters · filed 2026-03-19 | $1.39M derived: sum of 3 quarters · filed 2026-03-19 | $1.87M 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | $400.00K 10-Q · filed 2025-11-05 | $872.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.36M 10-Q · filed 2025-11-05 | $1.76M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $472.00K 10-Q · filed 2025-08-06 | $956.00K 10-Q · filed 2025-08-06 | $1.36M derived: sum of 3 quarters · filed 2025-08-06 | $1.90M derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | $484.00K 10-Q · filed 2025-05-07 | $884.00K derived: sum of 2 quarters · filed 2025-05-07 | $1.43M derived: sum of 3 quarters · filed 2025-05-07 | $1.61M derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $943.00K derived: sum of 2 quarters · filed 2025-03-12 | $1.13M derived: sum of 3 quarters · filed 2025-03-12 | $1.70M 10-K · filed 2025-03-12 | ||||
| 2023-09-30 | $543.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $726.00K derived: sum of 2 quarters · filed 2024-11-13 | $1.30M 10-Q · filed 2024-11-13 | $1.89M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $183.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $755.00K 10-Q · filed 2024-08-07 | $1.34M derived: sum of 3 quarters · filed 2024-08-07 | $1.91M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $572.00K 10-Q · filed 2024-05-08 | $1.16M derived: sum of 2 quarters · filed 2024-05-08 | $1.73M derived: sum of 3 quarters · filed 2024-05-08 | $2.48M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $587.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $1.15M derived: sum of 2 quarters · filed 2024-03-13 | $1.91M derived: sum of 3 quarters · filed 2024-03-13 | $2.68M 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | $566.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.32M derived: sum of 2 quarters · filed 2023-11-08 | $2.10M 10-Q · filed 2023-11-08 | $2.86M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $752.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.53M 10-Q · filed 2023-08-09 | $2.29M derived: sum of 3 quarters · filed 2023-08-09 | $3.05M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $777.00K 10-Q · filed 2023-05-03 | $1.54M derived: sum of 2 quarters · filed 2023-05-03 | $2.30M derived: sum of 3 quarters · filed 2023-05-03 | $3.14M derived: sum of 4 quarters · filed 2023-05-03 | ||||
| 2021-12-31 | $761.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $1.52M derived: sum of 2 quarters · filed 2023-03-08 | $2.36M derived: sum of 3 quarters · filed 2023-03-08 | $3.30M 10-K · filed 2023-03-08 | $3.30M 10-K · filed 2022-03-10 | |||
| 2021-09-30 | $761.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.60M derived: sum of 2 quarters · filed 2022-11-03 | $2.54M 10-Q · filed 2022-11-03 | $2.54M 10-Q · filed 2021-11-04 | $3.32M derived: sum of 4 quarters · filed 2022-11-03 | |||
| 2021-06-30 | $838.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.78M 10-Q · filed 2022-08-04 | $1.78M 10-Q · filed 2021-08-05 | $2.56M derived: sum of 3 quarters · filed 2022-08-04 | $3.30M derived: sum of 4 quarters · filed 2022-08-04 | |||
| 2021-03-31 | $942.00K 10-Q · filed 2022-05-05 | $942.18K 10-Q · filed 2021-05-06 | $1.72M derived: sum of 2 quarters · filed 2022-05-05 | $2.46M derived: sum of 3 quarters · filed 2022-05-05 | $3.46M derived: sum of 4 quarters · filed 2022-05-05 | |||
| 2020-12-31 | $775.76K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $1.52M derived: sum of 2 quarters · filed 2022-03-10 | $2.52M derived: sum of 3 quarters · filed 2022-03-10 | $3.27M 10-K · filed 2022-03-10 | ||||
| 2020-09-30 | $742.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.75M derived: sum of 2 quarters · filed 2021-11-04 | $2.49M 10-Q · filed 2021-11-04 | $3.70M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.75M 10-Q · filed 2021-08-05 | $2.95M derived: sum of 3 quarters · filed 2021-08-05 | $4.17M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $744.87K 10-Q · filed 2021-05-06 | $1.95M derived: sum of 2 quarters · filed 2021-05-06 | $3.17M derived: sum of 3 quarters · filed 2021-05-06 | $3.90M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $2.42M derived: sum of 2 quarters · filed 2021-03-11 | $3.15M derived: sum of 3 quarters · filed 2021-03-11 | $3.90M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $1.95M derived: sum of 2 quarters · filed 2020-11-12 | $2.69M 10-Q · filed 2020-11-12 | $3.83M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $726.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $1.47M 10-Q · filed 2020-08-13 | $2.61M derived: sum of 3 quarters · filed 2020-08-13 | $3.44M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $744.03K 10-Q · filed 2020-05-15 | $1.89M derived: sum of 2 quarters · filed 2020-05-15 | $2.71M derived: sum of 3 quarters · filed 2020-05-15 | $8.08M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $1.97M derived: sum of 2 quarters · filed 2020-03-30 | $7.33M derived: sum of 3 quarters · filed 2020-03-30 | $7.60M 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $826.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $6.19M derived: sum of 2 quarters · filed 2019-11-14 | $6.46M 10-Q · filed 2019-11-14 | $6.64M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $5.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $5.63M 10-Q · filed 2019-08-14 | $5.82M derived: sum of 3 quarters · filed 2019-08-14 | $5.98M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $267.14K 10-Q · filed 2019-05-15 | $451.11K derived: sum of 2 quarters · filed 2019-05-15 | $612.90K derived: sum of 3 quarters · filed 2019-05-15 | |||||
| 2017-12-31 | $183.96K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $345.75K derived: sum of 2 quarters · filed 2019-03-28 | $462.33K 10-K · filed 2019-03-28 | |||||
| 2017-09-30 | $161.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $278.37K 10-Q · filed 2018-11-14 | ||||||
| 2017-06-30 | $116.57K 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |